PUBLICACIÓN

The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases

ACCEDER A LA PUBLICACIÓN: Scopus Orcid Dialnet

Alonso-Navarro, H., Jiménez-Jiménez, F.J., García-Agúndez, J.A.

2006 Medicina Clinica


CITAS

5

DOI

10.1157/13088772

EID

2-s2.0-33745739711

ISSN

0025-7753

BIBTEX

@article { agundez2006,title = {The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases | Papel del polimorfismo genético CYP2C19 en los efectos adversos a fármacos y en el riesgo para diversas enfermedades},journal = {Medicina Clinica},year = {2006},volume = {126},number = {18},pages = {697-706},author = {Alonso-Navarro, H. and Jiménez-Jiménez, F.J. and García-Agúndez, J.A.}}


AUTORES DE LA UEX